Antares Pharma (NASDAQ:ATRS – Get Rating) and IRadimed (NASDAQ:IRMD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends. Valuation & Earnings This table compares Antares Pharma and IRadimed’s […]
IRadimed Co. (NASDAQ:IRMD – Get Rating) CEO Roger E. Susi sold 10,000 shares of the firm’s stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $43.90, for a total value of $439,000.00. Following the completion of the sale, the chief executive officer now directly owns 642,950 shares […]
Zacks Investment Research cut shares of IRadimed (NASDAQ:IRMD – Get Rating) from a buy rating to a hold rating in a report issued on Monday, Zacks.com reports. According to Zacks, “iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing […]
IRadimed Co. (NASDAQ:IRMD – Get Rating) CEO Roger E. Susi sold 10,000 shares of the firm’s stock in a transaction dated Thursday, April 7th. The stock was sold at an average price of $45.35, for a total transaction of $453,500.00. The sale was disclosed in a filing with the SEC, which is accessible through the […]
IRadimed (NASDAQ:IRMD – Get Rating) and Paragon 28 (NYSE:FNA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk and valuation. Profitability This table compares IRadimed and Paragon 28’s net margins, […]